Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02632578
What this trial is testing

Influenza Vaccine in HIV Study

Who this might be right for
Influenza, Human
University of Melbourne 57
Not applicableStudy completedNCT00812448
What this trial is testing

Catechin Containing Mask for the Prevention of Influenza Infection

Who this might be right for
Influenza Infection
University of Shizuoka 180
Testing effectiveness (Phase 2)Looking for participantsNCT05648448
What this trial is testing

Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Who this might be right for
InfluenzaInfluenza, Human
University of Oxford 3,000
Early research (Phase 1)Study completedNCT01236040
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old

Who this might be right for
Influenza
GlaxoSmithKline 521
Not applicableUnknownNCT02009735
What this trial is testing

Virosensor -Based Real-time Diagnosis of Enterovirus 71 and Influenza Virus

Who this might be right for
Enterovirus 71 and Influenza Virus
National Taiwan University Hospital 600
Post-approval studies (Phase 4)Study completedNCT01063608
What this trial is testing

Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff.

Who this might be right for
Influenza A Virus, H1N1 Subtype
Institut National de la Santé Et de la Recherche Médicale, France 147
Not applicableStudy completedNCT06668025
What this trial is testing

MxA-Guided Antiviral Treatment in Respiratory Viral Infections

Who this might be right for
Respiratory Viral InfectionsInfluenzaSARS CoV-2
Capital Medical University 86
Post-approval studies (Phase 4)Study completedNCT01001026
What this trial is testing

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults

Who this might be right for
H1N1/2009 Influenza
David Scheifele 156
Not applicableStudy completedNCT04110366
What this trial is testing

Nasal and Systemic Immune Responses to Nasal Influenza Vaccine

Who this might be right for
InfluenzaVaccine Virus Shedding
Imperial College Healthcare NHS Trust 48
Testing effectiveness (Phase 2)Study completedNCT06560151
What this trial is testing

Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59

Who this might be right for
Influenza
Biomedical Advanced Research and Development Authority 1,380
Testing effectiveness (Phase 2)Study completedNCT01896154
What this trial is testing

Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity

Who this might be right for
Immunosenescence
Clinical Research Center Kiel GmbH 239
Early research (Phase 1)Study completedNCT00489931
What this trial is testing

Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally

Who this might be right for
Influenza A Virus, H5N1 SubtypeInfluenza A VirusInfluenzavirus A+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 44
Not applicableStudy completedNCT00570037
What this trial is testing

Feasibility of Cocooning Immunization Strategy With Influenza Vaccine

Who this might be right for
Influenza
Duke University 544
Post-approval studies (Phase 4)Study completedNCT00743275
What this trial is testing

Evaluate the Safety and Immune Responses to Fluzone® Vaccination

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 120
Large-scale testing (Phase 3)Study completedNCT03390166
What this trial is testing

Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults

Who this might be right for
Influenza
Mahidol University 945
Testing effectiveness (Phase 2)Study completedNCT03682120
What this trial is testing

Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 372
Testing effectiveness (Phase 2)Study completedNCT00742885
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine

Who this might be right for
Influenza
GlaxoSmithKline 100
Testing effectiveness (Phase 2)Study completedNCT00980850
What this trial is testing

Swine Flu (Novel Influenza A H1N1) Vaccine Study

Who this might be right for
Influenza
University of Oxford 1,000
Early research (Phase 1)Study completedNCT05755620
What this trial is testing

Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT03698279
What this trial is testing

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 665
Next Page